Emily Feneberg
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Serum NfL and GFAP in post-COVID syndrome: minimal evidence of CNS injury after adjusting for confounders.
Journal: Frontiers in cellular neuroscience
Published: November 19, 2025
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord.
Journal: Acta neuropathologica communications
Published: May 06, 2025
Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.
Journal: Molecular neurodegeneration
Published: March 28, 2025
Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen.
Journal: Neurology
Published: February 13, 2025
Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study.
Journal: European journal of neurology
Published: July 10, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Neurology
Published: May 23, 2024
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons.
Journal: Brain communications
Published: February 13, 2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Journal: Alzheimer's research & therapy
Published: October 27, 2023
Parkinson's disease therapy: what lies ahead?
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 15, 2023
Last Updated: 09/26/2026